BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 1097236)

  • 21. Current status of antagonistic analogs of LH-RH as a contraceptive method in the female.
    Schally AV
    Res Front Fertil Regul; 1983 Jul; 2(5):1-16. PubMed ID: 12179624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-coital contraceptive and uterotrophic effects of luteinizing hormone releasing hormone.
    Corbin A; Beattie CW
    Endocr Res Commun; 1975; 2(6-7):445-58. PubMed ID: 1104348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of ovarian steroid feedback upon radioimmunoreactive luteinizing hormone releasing hormone in the hypothalamus.
    Yanaihara T; Arai K; Kanazawa M; Okinaga S; Yanaihara N; Yanaihara C
    Endocrinol Jpn; 1975 Dec; 22(6):525-30. PubMed ID: 782859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the anti-LH/FSH-RH and anti-ovulatory activities of (D-Phe2, D-Leu6)-LH-RH and (D-Phe2, D-Ala6)-LH-RH.
    Vilchez-Martinez JA; Coy DH; Coy EJ; Arimura A; Schally AV
    Endocr Res Commun; 1976; 3(3-4):231-41. PubMed ID: 786612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel peptides in ovarian follicular fluid: implications for contraceptive development.
    Schwartz NB
    Res Front Fertil Regul; 1982 Sep; 2(2):1-11. PubMed ID: 12179632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of gonadotropin-releasing hormone antagonists on serum follicle-stimulating hormone and luteinizing hormone under conditions of singular follicle-stimulating hormone secretion.
    Schwartz NB; Rivier C; Rivier J; Vale WW
    Biol Reprod; 1985 Mar; 32(2):391-8. PubMed ID: 3921074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of ovulation by progestin analogs (agonists vs antagonists): preliminary evidence for different sites and mechanisms of actions.
    Heikinheimo O; Gordon K; Williams RF; Hodgen GD
    Contraception; 1996 Jan; 53(1):55-64. PubMed ID: 8631191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of ovulation during discontinuous intranasal luteinizing hormone-releasing hormone agonist dosing in combination with gestagen-induced bleeding.
    Lemay A; Faure N; Labrie F; Fazekas AT
    Fertil Steril; 1985 Jun; 43(6):868-77. PubMed ID: 3158551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pituitary regulation of preovulatory estrogen secretion in the rat.
    Hori T; Ide M; Miyake T
    Endocrinol Jpn; 1969 Jun; 16(3):351-60. PubMed ID: 4309709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum gonadotropin concentrations and ovarian response in ewes treated with analogs to LH-RH/FSH-RH.
    Kinder JE; Adams TE; Nett TM; Coy DH; Schally AV; Reeves JJ
    J Anim Sci; 1976 May; 42(5):1220-6. PubMed ID: 773913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On differences between the preovulatory luteinizing hormone surges of 4- and 5-day cyclic rats.
    Schuiling GA; de Koning J; Zürcher AF
    J Endocrinol; 1976 Sep; 70(3):373-8. PubMed ID: 789803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic treatment with the gonadotropin-releasing hormone agonist D-Ser(TBU)6-EA10-LRH for contraception in women and men.
    Nillius SJ; Bergquist C; Wide L
    Int J Fertil; 1980; 25(3):239-46. PubMed ID: 6108935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ovulation inhibition with nafarelin acetate nasal administration for six months.
    Brenner PF; Shoupe D; Mishell DR
    Contraception; 1985 Dec; 32(6):531-51. PubMed ID: 2936564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-ovulatory/anti-pregnancy effects of (D-Phe2)-LRH analogs administered early in the rat estrous cycle.
    Beattie CW; Corbin A; Foell TJ; Garsky V; Rees RW; Yardley J
    Contraception; 1976 Mar; 13(3):341-53. PubMed ID: 765059
    [No Abstract]   [Full Text] [Related]  

  • 35. Changes in the concentration of LH, FSH and estrogen in the immature female rat during precocious sexual maturation induced by electrochemical stimulation of the brain.
    YoungLai EV; Holmes MJ; Ruf KB
    Horm Res; 1976; 7(1):34-42. PubMed ID: 1002115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of administration of anti-serum to luteinizing hormone-releasing hormone on gonadal function during the estrous cycle in the hamster.
    de la Cruz A; Arimura A; de la Cruz KG; Schally AV
    Endocrinology; 1976 Feb; 98(2):490-7. PubMed ID: 765124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in concentration of serum LH and FSH associated with estrogen-advanced ovulation in 4-day cyclic rats.
    Ying SY; Fang VS; Greep RO
    Proc Soc Exp Biol Med; 1972 Mar; 139(3):738-40. PubMed ID: 5063368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of daily low dose mifepristone on the ovarian cycle and on dynamics of follicle growth.
    Cameron ST; Thong KJ; Baird DT
    Clin Endocrinol (Oxf); 1995 Oct; 43(4):407-14. PubMed ID: 7586613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of the second surge of follicle-stimulating hormone; effects of antiluteinizing hormone-releasing hormone serum and pentobarbital.
    Hasegawa Y; Miyamoto K; Yazaki C; Igarashi M
    Endocrinology; 1981 Jul; 109(1):130-5. PubMed ID: 6786859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The acute feedback action of exogenously administered oestrogens on the serum-gonadotropin-levels in pre- and postmenopausal women (author's transl)].
    Czygan PJ; Reich W
    Arch Gynakol; 1973 May; 215(1):17-38. PubMed ID: 4582609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.